Profusa

Profusa company information, Employees & Contact Information

Explore related pages

Related company profiles:

Profusa’s mission is to make our body’s chemistry easily accessible to improve health and wellness. We are dedicated to becoming a leader in the development of real-time biosensors that provide unprecedented insights into our overall health status. We are leading the development of a new generation of biointegrated sensors that empowers the individual with the ability to monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Our technology enables the development of bioengineered sensors that become one with the body to detect and continuously transmit actionable, medical-grade data for personal and medical use. Profusa’s first clinical offering, the Lumee Oxygen Platform™, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. It may be used in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores) that do not heal properly; and reconstructive surgery. Any questions? Please visit profusa.com or email us at info@profusa.com

Company Details

Employees
54
Founded
-
Address
5959 Horton St,
Phone
(415)655-9861
Email
in****@****orp.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Emeryville, California
Looking for a particular Profusa employee's phone or email?

Profusa Questions

News

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026 - GlobeNewswire

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026 GlobeNewswire

Second $1M Investment: Profusa Expands Bitcoin Digital Treasury Strategy; Ascent Funds $2M Tranche - Stock Titan

Second $1M Investment: Profusa Expands Bitcoin Digital Treasury Strategy; Ascent Funds $2M Tranche Stock Titan

Profusa, Inc. Outlines Growth Strategy and Milestones in Shareholder Letter Following Nasdaq Listing - Quiver Quantitative

Profusa, Inc. Outlines Growth Strategy and Milestones in Shareholder Letter Following Nasdaq Listing Quiver Quantitative

Profusa Invests Additional $1 Million in Digital Treasury Assets - GlobeNewswire

Profusa Invests Additional $1 Million in Digital Treasury Assets GlobeNewswire

Digital Health Pioneer Profusa to Showcase Continuous Biochemistry Monitoring Tech at Major Conference - Stock Titan

Digital Health Pioneer Profusa to Showcase Continuous Biochemistry Monitoring Tech at Major Conference Stock Titan

Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy - The Manila Times

Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy The Manila Times

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base - GlobeNewswire

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base GlobeNewswire

Former Trump VA Secretary Who Led 9M-Patient Healthcare System Joins Biosensor Firm Profusa as Director - Stock Titan

Former Trump VA Secretary Who Led 9M-Patient Healthcare System Joins Biosensor Firm Profusa as Director Stock Titan

AI-Powered Continuous Biomarker Monitoring: Profusa Teams with NVIDIA for Revolutionary Health Portal - Stock Titan

AI-Powered Continuous Biomarker Monitoring: Profusa Teams with NVIDIA for Revolutionary Health Portal Stock Titan

300+ CLTI Patients Annually: Profusa's Oxygen Monitoring Tech Enters Major Belgian Hospital - Stock Titan

300+ CLTI Patients Annually: Profusa's Oxygen Monitoring Tech Enters Major Belgian Hospital Stock Titan

Profusa Announces Commercial and Clinical Collaboration - GlobeNewswire

Profusa Announces Commercial and Clinical Collaboration GlobeNewswire

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring - GlobeNewswire

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring GlobeNewswire

~35% EU Population Covered — Profusa Partners with Angiopro to Commercialize Lumee in Europe - Stock Titan

~35% EU Population Covered — Profusa Partners with Angiopro to Commercialize Lumee in Europe Stock Titan

Digital Health Pioneer Profusa Unveils $10B Market Strategy for Biochemistry Platform | PFSA Stock News - Stock Titan

Digital Health Pioneer Profusa Unveils $10B Market Strategy for Biochemistry Platform | PFSA Stock News Stock Titan

Leading Vascular Center Adopts Profusa's Real-Time Oxygen Monitoring Tech for 1,500 Annual Procedures - Stock Titan

Leading Vascular Center Adopts Profusa's Real-Time Oxygen Monitoring Tech for 1,500 Annual Procedures Stock Titan

Profusa (NASDAQ: PFSA) teams with Angiopro; Lumee to launch in Germany, Benelux, UK; EU 35% - Stock Titan

Profusa (NASDAQ: PFSA) teams with Angiopro; Lumee to launch in Germany, Benelux, UK; EU 35% Stock Titan

Profusa (NASDAQ: PFSA) to supply distributors in early 2026 as capacity exceeds needs by 2x - Stock Titan

Profusa (NASDAQ: PFSA) to supply distributors in early 2026 as capacity exceeds needs by 2x Stock Titan

Digital Health Innovator Profusa Launches on Nasdaq: Revolutionary Biosensor Platform Goes Public - Stock Titan

Digital Health Innovator Profusa Launches on Nasdaq: Revolutionary Biosensor Platform Goes Public Stock Titan

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy - Stock Titan

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy Stock Titan

Digital Health Leader Makes Historic $1M Bitcoin Investment, Partners With BlockFills for Crypto Treasury - Stock Titan

Digital Health Leader Makes Historic $1M Bitcoin Investment, Partners With BlockFills for Crypto Treasury Stock Titan

Profusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen - PR Newswire

Profusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen PR Newswire

Injectable Body Sensors Take Personal Chemistry to a Cell Phone Closer to Reality - PR Newswire

Injectable Body Sensors Take Personal Chemistry to a Cell Phone Closer to Reality PR Newswire

Profusa Unveils Biointegrated Sensors for Long-term Continuous Body Chemistry Monitoring - Diagnostic and Interventional Cardiology

Profusa Unveils Biointegrated Sensors for Long-term Continuous Body Chemistry Monitoring Diagnostic and Interventional Cardiology

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant